The efficacy of convalescent plasma for coronavirus disease 2019 (COVID-19) is unclear.
Although most randomized controlled trials have shown negative results, uncontrolled studies …

We previously reported that laboratory reference strains of Chlamydia trachomatis differing in
infection organotropism correlated with inactivating mutations in the pathogen’s tryptophan …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has been identified as
the causal agent of COronaVIrus Disease‐19 (COVID‐19), an atypical pneumonia‐like …

Most of the patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
mount a humoral immune response to the virus within a few weeks of infection, but the …

Delayed dosing intervals are a strategy to immunize a greater proportion of the population.
In an observational study, we compared humoral and cellular responses in health care …

Chlamydiae are obligate intracellular pathogens that can exhibit a broad host range in
infection tropism despite maintaining near genomic identity. Here, we have investigated the …

Widespread circulation of SARS-CoV-2 in humans raises the theoretical risk of reverse
zoonosis events with wildlife, reintroductions of SARS-CoV-2 into permissive nondomesticated …

There remains an urgent need for assays to quantify humoral protective immunity to SARS-CoV-2
to understand the immune responses of COVID-19 patients, evaluate efficacy of …

Gamma interferon (IFN-γ)-induced effector mechanisms have potent antichlamydial
activities that are critical to host defense. The most prominent and well-studied effectors are …

Better diagnostic tools are needed to combat the ongoing COVID-19 pandemic. Here, to
meet this urgent demand, we report a homogeneous immunoassay to detect IgG antibodies …